Abstract：【Objective】 To explore the clinical efficacy of Pudilan anti-inflammatory oral liquid combined with Tobramycin eye drops in the treatment of bacterial keratitis. 【Methods】 A total of 82 patients with bacterial keratitis admitted to our hospital from April 2020 to April 2023 were randomly divided into an observation group and a control group, with 41 cases in each group, using a random number table method. The control group was treated with tobramycin eye drops, while the observation group was treated with Pudilan anti-inflammatory oral solution in addition to the control group. Both groups were treated for 14 days. We compared the clinical efficacy, incidence of adverse reactions, clinical symptom scores before and after treatment, levels of interferon γ(IFN-γ), interleukin-6 (IL-6), tumor necrosis factor-α(TNF-α), and immune function indicators between two groups. 【Results】 After treatment, the pain symptom score, secretion symptom score, ulcer area symptom score, and conjunctival congestion symptom score of both groups decreased (P<0.05), and the observation group had a lower score (P<0.05). The total effective rate of the observation group was 92.68%, significantly higher than the control group's 75.61%, and the difference was statistically significant (P<0.05). Compared with before treatment, the serum IFN-γ levels in both groups increased after treatment (P<0.05), and the observation group had a higher level (P<0.05); After treatment, the serum levels of IL-6 and TNF-α decreased in both groups (P<0.05), and the observation group had lower levels (P<0.05). Compared with before treatment, the levels of CD3+ and CD4+ in both groups increased after treatment (P<0.05), and the observation group had a higher level (P<0.05); After treatment, the levels of CD8+ decreased in both groups (P<0.05), and the observation group had a lower level (P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05).【Conclusion】 The combination of Pudilan anti-inflammatory oral liquid and Tobramycin eye drops is effective in treating bacterial keratitis, improving clinical symptoms and immune function, reducing inflammatory reactions, and is safe and reliable.
杨凡, 王冠, 方莹. 蒲地蓝消炎口服液联合妥布霉素滴眼液治疗细菌性角膜炎的临床疗效[J]. 医学临床研究, 2024, 41(1): 43-46.
YANG Fan, WANG Guan, FANG Ying. Clinical Efficacy of Pudilan Anti-inflammatory Oral Liquid Combined with Tobramycin Eye Drops in the Treatment of Bacterial Keratitis. JOURNAL OF CLINICAL RESEARCH, 2024, 41(1): 43-46.
2024, Vol. 41 
